Lotus Eye Hospital and Institute Limited Financial Ratios
LOTUSEYE · Healthcare · Current price ₹112.51
P/E ratio
2812.8x
P/B ratio
3.8x
ROE
0.1%
ROCE
1.1%
Debt / Equity
0.26
Dividend yield
0.5%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 2812.8x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 3.8x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 0.1% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 1.1% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.26 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Lotus Eye Hospital and Institute Limited's latest numbers.
Lotus Eye Hospital and Institute Limited profitability
Lotus Eye Hospital and Institute Limited generates a return on equity of 0.1% and a return on capital employed of 1.1%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.26 and a P/E of 2812.8x, Lotus Eye Hospital and Institute Limited is conservatively financed. Our overall business-quality score for the company is 1.7 / 10.
Understand the ratios
More on Lotus Eye Hospital and Institute Limited
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.